BENZOIMIDAZOL-2-YL PYRIMIDINES AND PYRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR
申请人:EDWARDS James P.
公开号:US20100256373A1
公开(公告)日:2010-10-07
Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H
4
receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H
4
receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
Benzoimidazol-2-yl嘧啶和吡嗪,制药组合物和用于调节H4受体活性以及治疗由H4受体活性介导的疾病状态,紊乱和条件的方法,包括过敏,哮喘,自身免疫疾病和瘙痒症。